Intermedical Competitors

Stocks . Thailand . 
Stock . Intermedical Care and
IMH Stock  THB 4.78  0.02  0.42%   
Intermedical Care competes with Bangkok Dusit, Bangkok Dusit, Bangkok Chain, Chularat Hospital, and Chularat Hospital; as well as few others. The company operates under Healthcare sector and is part of Medical Care Facilities industry. Analyzing Intermedical Care competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Intermedical Care to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Intermedical Care Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Intermedical Care competition on your existing holdings.
  
Hype
Prediction
LowEstimatedHigh
3.694.785.87
Details
Intrinsic
Valuation
LowRealHigh
3.234.325.41
Details
Naive
Forecast
LowNextHigh
3.654.745.83
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
4.734.864.99
Details

Intermedical Care Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Intermedical Care and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Intermedical and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Intermedical Care does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
CHG-R
+ 0.93
BDMS-R
M-CHAI
+ 0.89
BDMS
EKH
+ 0.73
BDMS
M-CHAI
+ 0.73
EKH
EKH
+ 0.51
CHG
M-CHAI
+ 0.47
CHG
  
High negative correlations   
CHG
- 0.07
BDMS-R
M-CHAI
- 0.05
BDMS-R
BCH-R
- 0.02
BDMS-R
BDMS-R
- 0.02
BDMS

Risk-Adjusted Indicators

There is a big difference between Intermedical Stock performing well and Intermedical Care Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Intermedical Care's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Intermedical Care Competitive Analysis

The better you understand Intermedical Care competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Intermedical Care's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Intermedical Care's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
IMH BDMS BDMS-R BCH-R CHG-R CHG NTV EKH M-CHAI
 0.42 
 4.78 
Intermedical
 0.86 
 23.50 
Bangkok
 2.04 
 23.50 
Bangkok
 2.39 
 15.87 
Bangkok
 2.75 
 2.48 
Chularat
 0.81 
 2.48 
Chularat
 0.81 
 30.50 
Nonthavej
 1.64 
 6.00 
Ekachai
 0.91 
 27.75 
Mahachai
Market Volatility
(90 Days Market Risk)
Somewhat reliable
Very steady
Out of control
Out of control
Out of control
Moderately volatile
Very steady
Not too volatile
Very steady
Market Performance
(90 Days Performance)
Very Weak
Very Weak
OK
OK
OK
Very Weak
Very Weak
Very Weak
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Low
Low
Low
Low
Low
Low
Low
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Under Valued
Fairly Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Hold
Strong Sell
Strong Sell
Cautious Hold
Sell
Sell
Strong Sell
Current Ratio
5.66
1.53
0.79
0.7
1.25
1.38
4.82
2.68
0.27
Net Asset
1.18 B
128.45 B
128.45 B
26.38 B
10.55 B
10.55 B
2.53 B
1.33 B
12.3 B
Profit Margin
0.4
0.13
0.13
0.23
0.34
0.34
0.12
0.27
0.0884
EBITDA
568.07 M
17.64 B
17.64 B
10.38 B
5.65 B
5.65 B
354.25 M
501.85 M
1.13 B
Operating Margin
0.51
0.17
0.17
0.32
0.44
0.44
0.15
0.27
0.13
Current Valuation
2.81 B
454.24 B
454.24 B
53.68 B
39.32 B
39.32 B
5.44 B
5.05 B
12.25 B
Price To Book
3.17
5.22
5.54
4.06
5.46
5.46
2.79
3.8
2.24
Retained Earnings
N/A
29.95 B
28.38 B
1.04 B
888 M
876 M
1.25 B
N/A
N/A
Current Asset
N/A
13.33 B
12.76 B
1.87 B
1.42 B
1.42 B
522 M
N/A
N/A
Five Year Return
N/A
1.72
N/A
N/A
N/A
1.79
2.7
N/A
1.77
Beta
1.45
0.43
0.43
0.53
0.23
0.23
0.34
0.51
0.53
Number Of Employees
7
49
10
9
7
34
22
26
18
Shares Outstanding
214 M
15.89 B
15.89 B
2.49 B
11 B
11 B
160 M
674.89 M
16 M
Cash Flow From Operations
353.74 M
14.56 B
14.56 B
6.26 B
4.01 B
4.01 B
272.06 M
371.74 M
(328.9 M)
Annual Yield
0.0662
0.0174
0.0169
0.0382
0.0445
0.0445
0.0145
0.039
0.0196
Total Debt
85.45 M
12.5 B
12.5 B
3.98 B
313.49 M
313.49 M
N/A
35.15 M
4.57 B
Return On Equity
0.45
0.15
0.15
0.45
0.65
0.65
0.12
0.23
0.13
Z Score
20.4
21.6
21.6
7.8
82.0
80.2
N/A
N/A
0.6
Return On Asset
0.26
0.0739
0.0739
0.19
0.33
0.33
0.0812
0.12
0.0387
Book Value Per Share
4.1
5.41
5.41
4.89
0.66
0.66
14.53
2.24
138.17
Current Liabilities
N/A
12.98 B
16.25 B
3.01 B
1.13 B
645 M
203 M
N/A
N/A
Total Asset
1.18 B
128.45 B
128.45 B
26.38 B
10.55 B
10.55 B
2.53 B
1.33 B
12.3 B
Debt To Equity
0.2
0.22
0.57
0.93
0.21
0.27
N/A
0.038
2.73
Target Price
18.3
32.85
N/A
N/A
N/A
4.24
N/A
9.8
N/A
Last Dividend Paid
0.9
0.5
0.5
1.4
0.26
0.26
0.6
0.13
7.0
Shares Owned By Institutions
N/A
9.99
5.23
3.38
4.1
5.11
2.13
0.57
3.55
Market Capitalization
2.91 B
460.87 B
460.87 B
52.12 B
42.46 B
41.58 B
6.64 B
6.07 B
5.71 B
Price To Earning
N/A
62.6
42.31
46.68
55.0
45.12
31.35
50.32
38.71
Price To Earnings To Growth
N/A
2.34
N/A
N/A
N/A
2.2
N/A
N/A
N/A
Price To Sales
3.0
4.99
4.94
2.15
3.13
3.13
2.95
5.18
0.82
Net Income
422.7 M
7.94 B
7.94 B
6.85 B
4.2 B
4.2 B
159.37 M
344.83 M
386.7 M
Earnings Per Share
1.63
0.77
0.77
2.11
0.39
0.39
1.66
0.44
32.97
Shares Owned By Insiders
77.72
30.4
2.3
4.61
1.01
57.0
67.69
31.1
64.75
Revenue
942.64 M
74.45 B
74.45 B
21.4 B
11.74 B
11.74 B
1.79 B
1.15 B
4.7 B
Working Capital
N/A
346 M
(3.49 B)
(1.14 B)
288 M
773 M
319 M
N/A
N/A
Cash And Equivalents
115.41 M
10.89 B
5.01 B
806.38 M
389.99 M
1.16 B
764.94 M
237.21 M
98.89 M
Cash Per Share
0.54
0.69
0.32
0.32
0.04
0.1
4.78
0.4
6.18
Gross Profit
637.34 M
24.99 B
24.99 B
10.97 B
6.12 B
6.12 B
457.29 M
543.57 M
1.14 B
Day Typical Price
4.73
23.53
23.53
15.89
2.49
2.49
30.25
6.03
27.67
Accumulation Distribution
0.0417
3.4 M
0.021
0.0125
0.0315
486158.0
723.05
52989.11
0.009
Market Facilitation Index
0.2
N/A
0.5
0.2
0.08
N/A
0.0
N/A
0.25
Daily Balance Of Power
(0.10)
0.4
(0.98)
1.85
(0.88)
0.25
(0.33)
(0.50)
1.0
Period Momentum Indicator
(0.02)
0.2
(0.49)
0.37
(0.07)
0.02
(0.25)
(0.10)
0.25
Rate Of Daily Change
1.0
1.01
0.98
1.02
0.97
1.01
0.99
0.98
1.01
Day Median Price
4.7
23.55
23.55
15.9
2.5
2.5
30.13
6.05
27.63
Price Action Indicator
0.07
0.05
(0.29)
0.15
(0.06)
(0.01)
0.25
(0.10)
0.25
Relative Strength Index
27.56
25.91
50.0
45.88
44.4
44.94
47.96
41.22
34.08
Coefficient Of Variation
(509.50)
(405.53)
(716.65)
(768.39)
(472.11)
(1,333)
(2,224)
(561.30)
(644.90)
Mean Deviation
0.8196
1.09
0.4809
0.549
0.5913
1.54
0.5801
0.7275
1.1
Jensen Alpha
(0.23)
(0.35)
(0.26)
(0.17)
(0.25)
(0.16)
(0.04)
(0.19)
(0.26)
Total Risk Alpha
(0.26)
(0.40)
(0.31)
(0.20)
(0.29)
(0.21)
(0.07)
(0.21)
(0.30)
Standard Deviation
1.12
1.41
1.78
1.23
1.16
1.92
0.7559
0.9744
1.61
Kurtosis
0.7111
1.94
63.28
21.18
17.32
(0.35)
(0.58)
0.7505
3.73
Potential Upside
1.8
1.67
N/A
1.93
0.3745
2.82
0.8065
0.7874
2.63
Treynor Ratio
2.07
2.19
4.39
1.89
2.66
(0.41)
(5.00)
(1.10)
1.89
Maximum Drawdown
5.51
7.36
14.32
7.61
6.83
8.48
3.16
4.68
11.15
Variance
1.25
1.98
3.16
1.51
1.34
3.67
0.5714
0.9494
2.59
Market Risk Adjusted Performance
2.08
2.2
4.4
1.9
2.67
(0.40)
(4.99)
(1.09)
1.9
Risk Adjusted Performance
(0.15)
(0.19)
(0.11)
(0.1)
(0.16)
(0.05)
(0.04)
(0.14)
(0.12)
Skewness
(0.10)
0.7287
(7.90)
(3.57)
(2.83)
(0.16)
(0.34)
(0.86)
(0.36)
Information Ratio
(0.23)
(0.27)
(0.16)
(0.16)
(0.24)
(0.09)
(0.09)
(0.21)
(0.18)
Value At Risk
(2.57)
(2.51)
N/A
(2.08)
(2.24)
(3.65)
(1.57)
(2.26)
(3.05)

Intermedical Care Competition Performance Charts

Five steps to successful analysis of Intermedical Care Competition

Intermedical Care's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Intermedical Care in relation to its competition. Intermedical Care's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Intermedical Care in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Intermedical Care's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Intermedical Care, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Intermedical Care position

In addition to having Intermedical Care in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Railroads Thematic Idea Now

Railroads
Railroads Theme
Companies involved in manufacturing and maintenance of freight railroads and passenger trains as well as providing railroad services to public. The Railroads theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Railroads Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Intermedical Stock

Intermedical Care financial ratios help investors to determine whether Intermedical Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Intermedical with respect to the benefits of owning Intermedical Care security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY